«
‹
1
...
1062
1063
1064
1065
1066
1067
1068
1069
1070
...
5099
›
»
Page 1066 of 5099 · 254917 entries
Go to
| PDB ID | Title | official curves | Structure unit | Experimental Method |
|---|---|---|---|---|
| 2vtb | Structure of cryptochrome 3 - DNA complex | 3 | 3 | X-RAY DIFFRACTION |
| 2vtc | The structure of a glycoside hydrolase family 61 member, Cel61B from the Hypocrea jecorina. | 2 | 2 | X-RAY DIFFRACTION |
| 2vtd | Crystal structure of MurD ligase in complex with D-Glu containing sulfonamide inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 2vte | Crystal structure of MurD ligase in complex with D-Glu containing sulfonamide inhibitor | 1 | 1 | X-RAY DIFFRACTION |
| 2vtf | X-ray crystal structure of the Endo-beta-N-acetylglucosaminidase from Arthrobacter protophormiae E173Q mutant reveals a TIM barrel catalytic domain and two ancillary domains | 2 | 2 | X-RAY DIFFRACTION |
| 2vtg | Crystal Structure of Human Iba2, trigonal crystal form | 1 | 1 | X-RAY DIFFRACTION |
| 2vth | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design | 1 | 1 | X-RAY DIFFRACTION |
| 2vti | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. | 1 | 1 | X-RAY DIFFRACTION |
| 2vtj | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design | 1 | 1 | X-RAY DIFFRACTION |
| 2vtk | THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE 1 IN COMPLEX WITH ADP AND DEOXYTHYMIDINE | 1 | 1 | X-RAY DIFFRACTION |
| 2vtl | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design | 1 | 1 | X-RAY DIFFRACTION |
| 2vtm | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. | 1 | 1 | X-RAY DIFFRACTION |
| 2vtn | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. | 1 | 1 | X-RAY DIFFRACTION |
| 2vto | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. | 1 | 1 | X-RAY DIFFRACTION |
| 2vtp | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. | 1 | 1 | X-RAY DIFFRACTION |
| 2vtq | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. | 1 | 1 | X-RAY DIFFRACTION |
| 2vtr | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design | 1 | 1 | X-RAY DIFFRACTION |
| 2vts | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. | 1 | 1 | X-RAY DIFFRACTION |
| 2vtt | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. | 1 | 1 | X-RAY DIFFRACTION |
| 2vtu | crystal structure of bacteriophage MS2 covalent coat protein dimer | 2 | 6 | X-RAY DIFFRACTION |
| 2vtv | PhaZ7 depolymerase from Paucimonas lemoignei | 2 | 2 | X-RAY DIFFRACTION |
| 2vtw | Structure of the C-terminal head domain of the fowl adenovirus type 1 short fibre | 2 | 2 | X-RAY DIFFRACTION |
| 2vtx | ACTIVATION OF NUCLEOPLASMIN, AN OLIGOMERIC HISTONE CHAPERONE, CHALLENGES ITS STABILITY | 2 | 2 | X-RAY DIFFRACTION |
| 2vty | Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain swapped dimer | 1 | 1 | X-RAY DIFFRACTION |
| 2vtz | Biosynthetic thiolase from Z. ramigera. Complex of the C89A mutant with coenzyme A. | 1 | 1 | X-RAY DIFFRACTION |
| 2vu0 | Biosynthetic thiolase from Z. ramigera. Complex of the oxidised enzyme with coenzyme A. | 1 | 1 | X-RAY DIFFRACTION |
| 2vu1 | Biosynthetic thiolase from Z. ramigera. Complex of with O-pantheteine- 11-pivalate. | 1 | 1 | X-RAY DIFFRACTION |
| 2vu2 | Biosynthetic thiolase from Z. ramigera. Complex with S-pantetheine-11- pivalate. | 1 | 1 | X-RAY DIFFRACTION |
| 2vu3 | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. | 1 | 1 | X-RAY DIFFRACTION |
| 2vu4 | Structure of PsbP protein from Spinacia oleracea at 1.98 A resolution | 1 | 1 | X-RAY DIFFRACTION |
| 2vu5 | Crystal structure of Pndk from Bacillus anthracis | 1 | 1 | X-RAY DIFFRACTION |
| 2vu6 | Atomic resolution (0.95 A) structure of purified Thaumatin I grown in sodium meso-tartrate at 19 C. | 1 | 1 | X-RAY DIFFRACTION |
| 2vu7 | Atomic resolution (1.08 A) structure of purified thaumatin I grown in sodium meso-tartrate at 4 C | 1 | 1 | X-RAY DIFFRACTION |
| 2vu8 | Crystal structure of an insect inhibitor with a fungal trypsin | 1 | 1 | X-RAY DIFFRACTION |
| 2vu9 | CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN SEROTYPE A BINDING DOMAIN IN COMPLEX WITH GT1B | 1 | 1 | X-RAY DIFFRACTION |
| 2vua | Crystal Structure of the Botulinum Neurotoxin Serotype A binding domain | 1 | 1 | X-RAY DIFFRACTION |
| 2vub | CCDB, A TOPOISOMERASE POISON FROM E. COLI | 1 | 1 | X-RAY DIFFRACTION |
| 2vuc | PA-IIL lectin from Pseudomonas aeruginosa complexed with Fucose- derived glycomimetics | 1 | 1 | X-RAY DIFFRACTION |
| 2vud | PA-IIL lectin from pseudomonas aeruginosa complexed with fucose- derived glycomimetics | 1 | 1 | X-RAY DIFFRACTION |
| 2vue | Human serum albumin complexed with 4Z,15E-bilirubin-IX-alpha | 2 | 2 | X-RAY DIFFRACTION |
| 2vuf | Human serum albumin complexed with fusidic acid | 2 | 2 | X-RAY DIFFRACTION |
| 2vug | The structure of an archaeal homodimeric RNA ligase | 1 | 1 | X-RAY DIFFRACTION |
| 2vuh | Crystal structure of the D55E mutant of the HupR receiver domain | 1 | 1 | X-RAY DIFFRACTION |
| 2vui | Crystal structure of the HupR receiver domain in inhibitory phospho- state | 1 | 1 | X-RAY DIFFRACTION |
| 2vuj | Environmentally isolated GH11 xylanase | 1 | 1 | X-RAY DIFFRACTION |
| 2vuk | Structure of the p53 core domain mutant Y220C bound to the stabilizing small-molecule drug PhiKan083 | 2 | 2 | X-RAY DIFFRACTION |
| 2vul | Thermostable mutant of ENVIRONMENTALLY ISOLATED GH11 XYLANASE | 1 | 1 | X-RAY DIFFRACTION |
| 2vum | Alpha-amanitin inhibited complete RNA polymerase II elongation complex | 1 | 1 | X-RAY DIFFRACTION |
| 2vun | The Crystal Structure of Enamidase at 1.9 A Resolution - A new Member of the Amidohydrolase Superfamily | 1 | 1 | X-RAY DIFFRACTION |
| 2vuo | Crystal structure of the rabbit IgG Fc fragment | 1 | 1 | X-RAY DIFFRACTION |